摘要
Human microorganisms,including bacteria,fungi,and viruses,play key roles in several physiological and pathological processes.Some studies discovered that tumour tissues once considered sterile actually host a variety of microorganisms,which have been confirmed to be closely related to oncogenesis.The concept of intratumoural microbiota was subsequently proposed.Microbiota could colonise tumour tissues through mucosal destruction,adjacent tissue migration,and hematogenic invasion and affect the biological behaviour of tumours as an important part of the tumour microenvironment.Mechanistic studies have demonstrated that intratumoural microbiota potentially promote the initiation and progression of tumours by inducing genomic instability and mutations,affecting epigenetic modifications,promoting inflammation response,avoiding immune destruction,regulating metabolism,and activating invasion and metastasis.Since more comprehensive and profound insights about intratumoral microbiota are continuously emerging,new methods for the early diagnosis and prognostic assessment of cancer patients have been under examination.In addition,interventions based on intratumoural microbiota show great potential to open a new chapter in antitumour therapy,especially immunotherapy,although there are some inevitable challenges.Here,we aim to provide an extensive review of the concept,development history,potential sources,heterogeneity,and carcinogenic mechanisms of intratumoural microorganisms,explore the potential role of microorganisms in tumour prognosis,and discuss current antitumour treatment regimens that target intratumoural microorganisms and the research prospects and limitations in this field.
基金
supported by the National Natural Science Foundation of China(No.82330003,No.82070099,No.82102496,No.82001988)
National Science and Technology Major Project of the Ministry of Science and Technology of China(2022YFF1203300)
Major Project of the Department of Science and Technology of Hubei(2022BCA016)
Hubei Key Laboratory of Biological Targeted Therapy(2022swbx009).
作者简介
Yaqi Cao,contributed equally;Hui Xia,contributed equally;Xueyun Tan,contributed equally;Correspondence:Sufei Wang,wangsufei0@163.com;Correspondence:Yang Jin,whuhjy@126.com。
